Literature DB >> 33871213

Linezolid: A novel treatment option for the treatment of a non-responsive case of actinomycotic mycetoma.

Suman Patra1, Gridharan Senthilnathan1, M Ramam1, Sudheer Arava2, Neetu Bhari1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33871213     DOI： 10.25259/IJDVL_125_20

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN： 0378-6323            Impact factor:   2.545


× No keyword cloud information.
  9 in total

1.  Actinomycetoma and advances in its treatment.

Authors:  Oliverio Welsh; Lucio Vera-Cabrera; Esperanza Welsh; Mario Cesar Salinas
Journal:  Clin Dermatol       Date:  2012 Jul-Aug       Impact factor: 3.541

2.  Linezolid in the treatment of MDR-TB: a retrospective clinical study.

Authors:  H-B Xu; R-H Jiang; L Li; H-P Xiao
Journal:  Int J Tuberc Lung Dis       Date:  2012       Impact factor: 2.373

3.  A modified two-step treatment for actinomycetoma.

Authors:  M Ramam; Radhakrishna Bhat; Taru Garg; Vinod K Sharma; R Ray; M K Singh; U Banerjee; C Rajendran
Journal:  Indian J Dermatol Venereol Leprol       Date:  2007 Jul-Aug       Impact factor: 2.545

4.  A two-step schedule for the treatment of actinomycotic mycetomas.

Authors:  M Ramam; T Garg; P D'Souza; K K Verma; B K Khaitan; M K Singh; U Banerjee
Journal:  Acta Derm Venereol       Date:  2000 Sep-Oct       Impact factor: 4.437

5.  In vitro activities of linezolid against multiple Nocardia species.

Authors:  B A Brown-Elliott; S C Ward; C J Crist; L B Mann; R W Wilson; R J Wallace
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

Review 6.  Linezolid: a promising option in the treatment of Gram-positives.

Authors:  Abed Zahedi Bialvaei; Mohammad Rahbar; Mehdi Yousefi; Mohammad Asgharzadeh; Hossein Samadi Kafil
Journal:  J Antimicrob Chemother       Date:  2016-12-20       Impact factor: 5.790

7.  A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function.

Authors:  Waleed M Sweileh
Journal:  Fundam Clin Pharmacol       Date:  2009-08       Impact factor: 2.748

Review 8.  Linezolid for the treatment of Nocardia spp. infections.

Authors:  Tomasz Z Jodlowski; Igor Melnychuk; John Conry
Journal:  Ann Pharmacother       Date:  2007-09-04       Impact factor: 3.154

9.  In vitro activities of new quinolones and oxazolidinones against Actinomadura madurae.

Authors:  Lucio Vera-Cabrera; Elsa Y Ochoa-Felix; Gloria Gonzalez; Rolando Tijerina; Sung H Choi; Oliverio Welsh
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.